These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma. Buzaid A; Legha SS; Balch CM; Ross M; Ring S; Plager C; Papadopoulos NE; el-Naggar AK; Benjamin RS Cancer; 1994 Nov; 74(9):2476-82. PubMed ID: 7923003 [TBL] [Abstract][Full Text] [Related]
4. Pilot study of intra-arterial cisplatin and intravenous vinblastine and dacarbazine in patients with melanoma in-transit metastases. Eton O; East M; Legha SS; Bedikian A; Buzaid AC; Papadopoulos N; Hodges C; Gianan M; Carrasco CH; Benjamin RS Melanoma Res; 1999 Oct; 9(5):483-9. PubMed ID: 10596915 [TBL] [Abstract][Full Text] [Related]
5. Arterial infusion of dacarbazine and cisplatin for recurrent regionally confined melanoma. Frost DB; Patt YZ; Mavligit G; Chuang VP; Wallace S Arch Surg; 1985 Apr; 120(4):478-80. PubMed ID: 4039130 [TBL] [Abstract][Full Text] [Related]
6. Isolated limb perfusion for recurrent melanoma of the extremity. Reintgen DS; Cruse CW; Wells KE; Saba HI; Slingluff CL Ann Plast Surg; 1992 Jan; 28(1):50-4. PubMed ID: 1642406 [TBL] [Abstract][Full Text] [Related]
7. Tourniquet infusion with DTIC in therapy-resistant melanoma on the extremities: a pilot study. Jönsson PE; Ingvar C; Stridbeck H Recent Results Cancer Res; 1983; 86():213-7. PubMed ID: 6648001 [No Abstract] [Full Text] [Related]
8. Tourniquet infusion chemotherapy of the lower extremities--clinical and pharmacokinetic results. Ingvar C; Eksborg S; Stigsson L; Jönsson PE Eur J Surg Oncol; 1989 Aug; 15(4):375-9. PubMed ID: 2759256 [TBL] [Abstract][Full Text] [Related]
9. A phase II study of the efficacy of diamminedichloroplatinum (cisplatin) for the control of locally recurrent and intransit malignant melanoma of the extremities using tourniquet outflow-occlusion techniques. Bland KI; Kimura AK; Brenner DE; Basinger MA; Hirsch M; Hawkins IF; Pierson KK; Copeland EM Ann Surg; 1989 Jan; 209(1):73-80. PubMed ID: 2910216 [TBL] [Abstract][Full Text] [Related]
10. Comparing intra-arterial chemotherapy combined with intravesical chemotherapy versus intravesical chemotherapy alone: a randomised prospective pilot study for T1G3 bladder transitional cell carcinoma after bladder-preserving surgery. Chen J; Yao Z; Qiu S; Chen L; Wang Y; Yang J; Li J Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1521-1526. PubMed ID: 23511989 [TBL] [Abstract][Full Text] [Related]
11. Improved durable responses regardless of age following cytoreduction and "no-tourniquet" hyperthermic isolated limb chemotherapy for in transit melanoma of the extremity. Wang T; Osborne N; Rechtenwald J; Kim A; Matusko N; Mayle R; Cohen MS Am J Surg; 2019 Dec; 218(6):1114-1121. PubMed ID: 31630826 [TBL] [Abstract][Full Text] [Related]
12. Treatment of stage IV malignant melanoma with dacarbazine, carmustine, cisplatin, and tamoxifen regimens: a University of South Florida and H. Lee Moffitt Melanoma Center Study. Saba HI; Cruse CW; Wells KE; Klein CJ; Reintgen DS Ann Plast Surg; 1992 Jan; 28(1):65-9. PubMed ID: 1642409 [TBL] [Abstract][Full Text] [Related]
13. Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma. Johnston SR; Constenla DO; Moore J; Atkinson H; A'Hern RP; Dadian G; Riches PG; Gore ME Br J Cancer; 1998 Apr; 77(8):1280-6. PubMed ID: 9579834 [TBL] [Abstract][Full Text] [Related]
14. Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: a randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group. Punt CJ; Suciu S; Gore MA; Koller J; Kruit WH; Thomas J; Patel P; Lienard D; Eggermont AM; Keilholz U Eur J Cancer; 2006 Nov; 42(17):2991-5. PubMed ID: 17023156 [TBL] [Abstract][Full Text] [Related]
15. Isolated limb perfusion for stage I melanoma of the extremity: a comparison of melphalan and dacarbazine (DTIC). Edwards MJ; Boddie AW; Ames FC; McBride CM South Med J; 1989 Aug; 82(8):985-7, 989. PubMed ID: 2762904 [TBL] [Abstract][Full Text] [Related]
16. Treatment of metastatic malignant melanoma with 24 hours continuous venous infusion of dacarbazine and cisplatin. Icli F; Karaoguz H; Dincol D; Gunel N; Demirkazik A J Surg Oncol; 1991 Nov; 48(3):199-201. PubMed ID: 1943117 [TBL] [Abstract][Full Text] [Related]
17. Phase II randomized trial comparing high-dose IFN-α2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma. Lian B; Si L; Cui C; Chi Z; Sheng X; Mao L; Li S; Kong Y; Tang B; Guo J Clin Cancer Res; 2013 Aug; 19(16):4488-98. PubMed ID: 23833309 [TBL] [Abstract][Full Text] [Related]
18. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. Serrone L; Zeuli M; Sega FM; Cognetti F J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932 [TBL] [Abstract][Full Text] [Related]
19. Regional isolated perfusion of extremities for melanoma: a 20-year experience with drugs other than L-phenylalanine mustard. Ariyan S; Poo WJ; Bolognia J Plast Reconstr Surg; 1997 Apr; 99(4):1023-9. PubMed ID: 9091898 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy in malignant melanoma using dacarbazine, carmustine, cisplatin, and tamoxifen: a University of South Florida and H. Lee Moffitt Melanoma Center Study. Saba HI; Cruse CW; Wells KE; Klein CJ; Reintgen DS Ann Plast Surg; 1992 Jan; 28(1):60-4. PubMed ID: 1642408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]